Drug Information

Drug General Information
Drug ID
D08EUS
Former ID
DNCL003476
Drug Name
CGC-11047
Drug Type
Small molecular drug
Indication Prostate cancer [ICD9: 185; ICD10:C61] Phase 2 [522195]
Company
Progen Pharmaceuticals
Structure
Download
2D MOL

3D MOL
Formula
C14H32N4
Canonical SMILES
CCNCCCNCC=CCNCCCNCC
InChI
1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5-
InChIKey
XFWLTFZLLXVKDY-WAYWQWQTSA-N
PubChem Compound ID
6475492
PubChem Substance ID
634239, 11990132, 15441176, 43065682, 80428693, 103384962, 114524975, 142061806, 194943261, 228477751
Target and Pathway
Target(s) Human DNA Target Info Modulator [530183]
References
Ref 522195ClinicalTrials.gov (NCT00585416) Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer. U.S. National Institutes of Health.
Ref 530183Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047. Cancer Genomics Proteomics. 2009 May-Jun;6(3):161-75.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.